GMAB:NASDAQ
Genmab A/S - ADR
US$ ५०.७७
arrow_downward
-१.१३%(-०.५८) 1D
नोभेम्बर २०, १३:०६:२४ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
US$ ५१.५७
High
US$ ५१.७२
Low
US$ ५०.६२
Mkt. cap
३१.७७ अरब
Avg. vol.
५४.३५ लाख
Volume
१३.४३ लाख
P/E ratio
४३.२४
52-wk high
US$ ५९.९७
52-wk low
US$ २३.६२
EPS
US$ १.१७
Beta
०.७३
Shares outstanding
६२.५७ करोड
No. of employees
३ हजार
Open
US$ ५१.५७
High
US$ ५१.७२
Low
US$ ५०.६२
Mkt. cap
३१.७७ अरब
Avg. vol.
५४.३५ लाख
Volume
१३.४३ लाख
P/E ratio
४३.२४
52-wk high
US$ ५९.९७
52-wk low
US$ २३.६२
EPS
US$ १.१७
Beta
०.७३
Shares outstanding
६२.५७ करोड
No. of employees
३ हजार
News stories
From web sources and news partners
Investor's Business Daily
·
५ घण्टा पहिले
Genmab's Scores A 'Hat Trick' And Cruises 60% In A Month. What Comes Next.
Benzinga
·
१ दिन पहिले
Keith Manchester Sells $54M Of Roivant Sciences Stock After Sharp Run-Up
StreetInsider
·
१ दिन पहिले
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S - ADR
CEOJan G. J. van de Winkel
Employees३.२४ हजार
Founded१९९९
Headquarters-
SectorHealth Care
Industry-
Websitegenmab.com